Skip to content
healthcare.dev
Get a free key

Crcle Guaifenesin Extended-Release Tablets, 600 mg

NDC 57483-270, Guaifenesin Extended-Release, tablet, from Innovus Pharmaceuticals, Inc..

Product NDC
57483-270
Status
Listed
Labeler
Innovus Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57483-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
57483-270-01574830270015 BLISTER PACK in 1 CARTON (57483-270-01) / 20 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 57483-270 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57483-270 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57483-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.